Evidence map›Paper›PMID 42723639›Full record

Observational studyF1000Research2026

Dynamics of Body Mass Index and Serum Albumin Levels Before and After the Intensive Phase of Tuberculosis Treatment.

Lisna Rosalia Agaus, Muh Ilyas, Agus Sudarso, Syakib Bakri, Haerani Rasyid, Andi Alfian Zainuddin

Abstract readObservational Study
In one paragraph

Observational study in F1000Research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lisna Rosalia AgausFaculty of Medicine, Hasanuddin University, Makassar, South Sulawesi, Indonesia.ORCID https://orcid.org/0009-0001-3935-4450
Muh IlyasFaculty of Medicine, Hasanuddin University, Makassar, South Sulawesi, Indonesia.
Agus SudarsoFaculty of Medicine, Hasanuddin University, Makassar, South Sulawesi, Indonesia.
Syakib BakriFaculty of Medicine, Hasanuddin University, Makassar, South Sulawesi, Indonesia.
Haerani RasyidFaculty of Medicine, Hasanuddin University, Makassar, South Sulawesi, Indonesia.
Andi Alfian ZainuddinDepartment of Public Health and Community Medicine, Hasanuddin University, Makassar, South Sulawesi, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Tuberculosis remains a major global health problem and is frequently associated with malnutrition, which can negatively affect treatment outcomes. This study aimed to evaluate changes in body mass index (BMI) and serum albumin levels before and after the intensive phase of tuberculosis treatment. Methods: An observational analytic study with a prospective cohort design was conducted at Dr. Wahidin Sudirohusodo Hospital, Makassar. A total of 175 newly diagnosed tuberculosis patients were enrolled. BMI and serum albumin levels were measured at baseline and after completion of the two-month intensive treatment phase. Paired sample Results: BMI increased significantly from 19.21 ± 3.55 kg/m Conclusions: Intensive-phase anti-tuberculosis therapy is associated with significant improvements in both anthropometric and biochemical nutritional parameters. Routine monitoring of BMI and serum albumin may serve as practical indicators for assessing treatment response and guiding nutritional interventions in tuberculosis patients.

Indexed as

Antitubercular AgentsBody Mass IndexSerum AlbuminTuberculosisAdultFemaleHumansMaleMiddle AgedNutritional StatusProspective StudiesTreatment OutcomeAntitubercular AgentsSerum AlbuminBody Mass IndexIntensive Phase TreatmentNutritional StatusSerum AlbuminTuberculosis

Identifiers

PMID42723639
PMCPMC13550917

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.